Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics
| dc.contributor.author | López, Abraham |
| dc.contributor.author | Herranz-Trillo, Fátima |
| dc.contributor.author | Kotev, Martin |
| dc.contributor.author | Gairí, Margarida |
| dc.contributor.author | Guallar, Víctor |
| dc.contributor.author | Bernadó, Pau |
| dc.contributor.author | Millet, Oscar |
| dc.contributor.author | Tarragó, Teresa |
| dc.contributor.author | Giralt, Ernest |
| dc.contributor.other | Barcelona Supercomputing Center |
| dc.date.accessioned | 2017-01-30T15:01:48Z |
| dc.date.available | 2017-05-17T00:30:20Z |
| dc.date.issued | 2016-05-17 |
| dc.description.abstract | Deciphering conformational dynamics is crucial for understanding the biological functions of proteins and for designing compounds targeting them. In particular, providing an accurate description of microsecond–millisecond motions opens the opportunity for regulating protein–protein interactions (PPIs) by modulating the dynamics of one interacting partner. Here we analyzed the conformational dynamics of prolyl oligopeptidase (POP) and the effects of active-site-directed inhibitors on the dynamics. We used an integrated structural biology approach based on NMR spectroscopy and SAXS experiments complemented by MD simulations. We found that POP is in a slow equilibrium in solution between open and closed conformations, and that inhibitors effectively abolished this equilibrium by stabilizing the enzyme in the closed conformation. |
| dc.description.peerreviewed | Peer Reviewed |
| dc.description.sponsorship | This work was supported by the Institute for Research in Biomedicine, MINECO-FEDER (Bio2013-40716-R, CTQ2013-48287 and CTQ2012-32183/BQU), and the Generalitat de Catalunya (XRB and Grup Consolidat 2014SGR521). AL has received funding from the Instituto de Salud Carlos III. PB acknowledges the Agence Nationale de la Recherche (SPINHD-ANR-CHEX-2011) and the ATIP-Avenir program for financial support. FHT’s fellowship is co-funded by the INSERM and the University of Copenhagen. Technical assistance from staff at the P12 beam line (EMBL/DESY) is acknowledged. |
| dc.description.version | Postprint (author's final draft) |
| dc.format.extent | 5 p. |
| dc.identifier.citation | López, Abraham [et al.]. Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics. "ChemBioChem", 17 Maig 2016, vol. 17, núm. 10, p. 913-917. |
| dc.identifier.doi | 10.1002/cbic.201600102 |
| dc.identifier.issn | 1439-4227 |
| dc.identifier.uri | https://hdl.handle.net/2117/100311 |
| dc.language.iso | eng |
| dc.publisher | Wiley |
| dc.relation.projectid | info:eu-repo/grantAgreement/MINECO//BIO2013-40716-R/ES/PEPTIDOS COMO AGENTES TERAPEUTICOS: MODULACION DE INTERACCIONES PROTEINA-PROTEINA Y TRANSPORTE AL CEREBRO/ |
| dc.relation.projectid | info:eu-repo/grantAgreement/MINECO//CTQ2013-48287-R/ES/DISENYO COMPUTACIONAL RACIONAL DE OXIDOREDUCTASAS PARA APLICACIONES INDUSTRIALES Y TECNOLOGICAS/ |
| dc.relation.projectid | info:eu-repo/grantAgreement/MINECO/1PE/CTQ2012-32183/BQU |
| dc.relation.publisherversion | http://onlinelibrary.wiley.com/doi/10.1002/cbic.201600102/abstract |
| dc.rights.access | Open Access |
| dc.subject | Àrees temàtiques de la UPC::Enginyeria biomèdica |
| dc.subject.lcsh | Proteins--Analysis |
| dc.subject.lemac | Proteïnes--Anàlisi |
| dc.subject.other | Protein–protein interactions (PPIs) |
| dc.subject.other | Prolyl oligopeptidase (POP) |
| dc.title | Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics |
| dc.type | Article |
| dspace.entity.type | Publication |
| local.citation.endingPage | 917 |
| local.citation.number | 10 |
| local.citation.publicationName | ChemBioChem |
| local.citation.startingPage | 913 |
| local.citation.volume | 17 |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- Active Site-Directed Inhibitors of Prolyl Oligopeptidase.pdf
- Mida:
- 2.23 MB
- Format:
- Adobe Portable Document Format
- Descripció:



